These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33500631)

  • 1. Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer.
    Wu J; Xu H; Ji H; Zhai B; Zhu J; Gao M; Zhu H; Wang X
    Onco Targets Ther; 2021; 14():577-587. PubMed ID: 33500631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratin17 Promotes Tumor Growth and is Associated with Poor Prognosis in Gastric Cancer.
    Hu H; Xu DH; Huang XX; Zhu CC; Xu J; Zhang ZZ; Zhao G
    J Cancer; 2018; 9(2):346-357. PubMed ID: 29344281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel iron zinc finger protein 36 (ZFP36) for predicting the overall survival of osteosarcoma based on the Gene Expression Omnibus (GEO) database.
    Song P; Xie Z; Chen C; Chen L; Wang X; Wang F; Xie X; Hong X; Wang Y; Wu X
    Ann Transl Med; 2021 Oct; 9(20):1552. PubMed ID: 34790758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer.
    Zhang C; Gou X; He W; Yang H; Yin H
    Cancer Cell Int; 2020; 20():177. PubMed ID: 32467671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis.
    Wang Z; Yang MQ; Lei L; Fei LR; Zheng YW; Huang WJ; Li ZH; Liu CC; Xu HT
    Cancer Manag Res; 2019; 11():7485-7497. PubMed ID: 31496806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis
    Wu J; Li T; Ji H; Chen Z; Zhai B
    Front Pharmacol; 2022; 13():874235. PubMed ID: 35559251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRT17 as a prognostic biomarker for stage II colorectal cancer.
    Ujiie D; Okayama H; Saito K; Ashizawa M; Thar Min AK; Endo E; Kase K; Yamada L; Kikuchi T; Hanayama H; Fujita S; Sakamoto W; Endo H; Saito M; Mimura K; Saze Z; Momma T; Ohki S; Kono K
    Carcinogenesis; 2020 Jul; 41(5):591-599. PubMed ID: 31754689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prognostic Model of Bladder Cancer Based on Metabolism-Related Long Non-Coding RNAs.
    Hu J; Lai C; Shen Z; Yu H; Lin J; Xie W; Su H; Kong J; Han J
    Front Oncol; 2022; 12():833763. PubMed ID: 35280814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
    Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ
    BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin 17 Promotes Lung Adenocarcinoma Progression by Enhancing Cell Proliferation and Invasion.
    Liu J; Liu L; Cao L; Wen Q
    Med Sci Monit; 2018 Jul; 24():4782-4790. PubMed ID: 29991674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
    Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
    Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
    Lu H; Wu J; Liang L; Wang X; Cai H
    Front Immunol; 2022; 13():803355. PubMed ID: 35154117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer.
    Chen M; Nie Z; Cao H; Gao Y; Wen X; Zhang C; Zhang S
    Pathol Oncol Res; 2021; 27():598460. PubMed ID: 34257551
    [No Abstract]   [Full Text] [Related]  

  • 15. [Construction of prognostic model and identification of prognostic biomarkers based on the expression of long non-coding RNA in bladder cancer via bioinformatics].
    Yang FL; Hong K; Zhao GJ; Liu C; Song YM; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):615-622. PubMed ID: 31420610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma.
    Liu X; Zhang W; Wang H; Lai CH; Xu K; Hu H
    PeerJ; 2020; 8():e10281. PubMed ID: 33194434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X
    Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
    Liu A; Xue Y; Liu F; Tan H; Xiong Q; Zeng S; Zhang Z; Gao X; Sun Y; Xu C
    Cancer Biomark; 2019; 26(3):281-289. PubMed ID: 31594208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.